Careers | Life at OML

Our people are our greatest asset. We employ the brightest, most talented and passionate people who can help us achieve our mission.

The problems we are trying to solve at Owlstone Medical are enormously difficult. To enable our progress, we’ve fostered a dynamic working environment that allows our talented and dedicated multidisciplinary team to flourish, work together and help each other.

Our ethos is passionate and determined but also fast-paced and flexible. We’re always prepared to follow the data – and we have a lot of fun together too!

In September 2023 we were proud to be a Silver Winner for ‘Employer of the Year’ at the annual SME Cambridge Business Awards – an award which recognizes our company-wide commitment and dedication to looking after our employees.

Emily Bollom

Sarah Found

“Everyone is friendly, helpful, supportive, and I truly feel so fortunate to be part of this amazing team, which is trying to do something so hard, but so worthwhile!” – Roxy

“At Owlstone, my colleagues are working to save lives! Working here feels far more meaningful and rewarding than anywhere I have worked before.” – Veronika

“I really enjoy working in such a diverse environment alongside experts in engineering, clinical trials, marketing and sales, and of course biomedical research.” – Giuseppe

A very sociable team

Our Social Committee works to keep everybody at Owlstone Medical feeling included with a range of clubs and societies such as netball and football for our sport enthusiasts, book clubs and learning societies, flamenco dancing, cocktail masterclasses, alongside regular company-wide social events.

And with the help of our Green Committee we’re continuously improving on our commitment to be a green place to work.

We believe that big problems can only be solved by working smart and working together, so we’ve created spaces that encourage collaboration, but we have also reserved areas where people can focus on their own.

We find that our toughest challenges are solved by our people coming together in our fantastic offices. In support of this we offer flexible working arrangements, with a balance of hybrid and office working depending on your role.

Company News

Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection
Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection
Owlstone Medical Launches Breath Biopsy VOC Atlas
Owlstone Medical Appoints Mark Capone to Board of Directors
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the appointment of Mark Capone, former President and CEO of Myriad Genetics to its Board as an independent non-executive director.
Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the close of its Series D financing round, securing $58 million and bringing the total raised by the company to over $150 million since founding in 2016.
Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic
Owlstone Medical (“OML”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced agreements with Functional Gut Clinic (“FGC”) and Functional Gut Diagnostics (“FGD”), leading providers of smart solutions for the diagnosis of gut health problems.
Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection
Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection
Owlstone Medical Launches Breath Biopsy VOC Atlas
Owlstone Medical Appoints Mark Capone to Board of Directors
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the appointment of Mark Capone, former President and CEO of Myriad Genetics to its Board as an independent non-executive director.
Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the close of its Series D financing round, securing $58 million and bringing the total raised by the company to over $150 million since founding in 2016.
Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic
Owlstone Medical (“OML”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced agreements with Functional Gut Clinic (“FGC”) and Functional Gut Diagnostics (“FGD”), leading providers of smart solutions for the diagnosis of gut health problems.

Are you a smart professional seeking a new challenge? Come and join our team.